title: Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?
authors.forename: Armelle
authors.initials: A
authors.lastname: Pasquet
authors.forename: Nathalie
authors.initials: N
authors.lastname: Viget
authors.forename: Faiza
authors.initials: F
authors.lastname: Ajana
authors.forename: Xavier
authors.initials: X
authors.lastname: de la Tribonniere
authors.forename: Sandrine
authors.initials: S
authors.lastname: Dubus
authors.forename: Julien
authors.initials: J
authors.lastname: Paccou
authors.forename: Isabelle
authors.initials: I
authors.lastname: Legroux-Gérot
authors.forename: Hugues
authors.initials: H
authors.lastname: Melliez
authors.forename: Bernard
authors.initials: B
authors.lastname: Cortet
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
mesh_terms: D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines / Q000009:adverse effects*; D003521:Cyclopropanes; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D014808:Vitamin D Deficiency / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz